Drug regulator halts production at 76 units over poor standards

More than 75% of the firms have also been issued show cause notices, the people said. Out of the total samples drawn from these manufacturing units, 15.1% have so far been declared to be of not of standard quality (NSQ). The regulator is currently conducting Phase IV of these inspections.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ziRvopk
via IFTTT